SEROCTIN RESEARCH v. UNIGEN PHARMACEUTICALS

No. 2:07-CV-582 TC.

541 F.Supp.2d 1238 (2008)

SEROCTIN RESEARCH & TECHNOLOGIES, INC, a Nevada Corporation, Plaintiff, v. UNIGEN PHARMACEUTICALS, INC., a Colorado Corporation, Univera Life Sciences, dba Oasis Life Sciences, a Colorado Corporation, and Does 1-100, Defendants.

United States District Court, D. Utah, Central Division.

February 11, 2008.


Attorney(s) appearing for the Case

Larry R. Laycock, Brett I. Johnson, Charles L. Roberts, David R. Wright, Workman Nydegger, Salt Lake City, UT, for Plaintiff.

David O. Seeley, George M. Haley, Cory A. Talbot, Holme Roberts & Owen, Salt Lake City, UT, for Defendants.


ORDER AND MEMORANDUM DECISION

TENA CAMPBELL, Chief Judge.

This case involves a dispute over United States Patent No. 6,667,308 ("the '308 patent") and a licensing agreement for that patent. The '308 patent makes claims on various uses of several chemical compounds, including 6-methoxy-2, 3-benzoxazolinone ("6-MBOA"). Seroctin Research & Technologies, Inc. ("SRT") holds the '308 patent and has entered into an agreement with Unigen Pharmaceuticals, Inc...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases